Rather, at each stage, serum FAS concentrations were significantly higher in the cancer patients than in the healthy subjects, indicating that serum FAS could aid in the early diagnosis of gastric cancer and that the determination of serum FAS concentration may possibly be used as a primary screening test for gastric cancer. This evidence concerns the gene FAS and cancer.